Nautilus CEO Sujal Patel Delays Biotech Product Launch to Late 2026, Lays Off 16% Workforce Amid Strategic Shift

Nautilus Biotechnology laid off 16% of its workforce and delayed its product launch to late 2026 to pursue a higher-performance proteomics platform. CEO Sujal Patel emphasized the company’s strong financial position with over $206 million in cash despite the stock price drop.